
The Library
Assessing readiness to implement routine immunization among patent and proprietary medicine vendors in Kano, Nigeria : a theory-informed cross-sectional study
Tools
Adamu, Abdu A., Gadanya, Muktar A., Jalo, Rabiu I., Uthman, Olalekan A., Nnaji, Chukwudi A., Bello, Imam W. and Wiysonge, Charles S. (2020) Assessing readiness to implement routine immunization among patent and proprietary medicine vendors in Kano, Nigeria : a theory-informed cross-sectional study. Expert Review of Vaccines, 19 (4). pp. 395-405. doi:10.1080/14760584.2020.1750379 ISSN 1476-0584.
|
PDF
WRAP-assessing-readiness-implement-routine-immunization-among-patent-proprietary-medicine-vendors-Kano-Nigeria-Uthman-2020.pdf - Accepted Version - Requires a PDF viewer. Download (920Kb) | Preview |
Official URL: http://dx.doi.org/10.1080/14760584.2020.1750379
Abstract
Background:
Patent and proprietary medicine vendors (PPMVs) are widespread in communities and can potentially be used to expand access to routine immunization especially in underserved areas. In this study, we aimed to assess their readiness to implement routine immunization in Kano, Nigeria and identify factors associated with it.
Methods:
We conducted a cross-sectional survey of PPMVs aged 18 years and above in Kano metropolis, Nigeria, using cluster sampling technique. A 10-item Likert scale-based measure was used to estimate readiness score. The relationship between selected factors and readiness score was examined using multilevel linear modeling technique.
Results:
A total of 455 PPMVs with median age of 36 years participated in the study. The median raw score for readiness was 4.7 (IQR: 4.3 – 4-8) (maximum obtainable was 5). The mean readiness score (obtained through factor analysis) was 5.28 (SD: 0.58). Readiness score was associated with factors such as knowledge of immunization and task demand, engagement by other public health programs among others.
Conclusion:
This study demonstrated the feasibility of measuring the level of readiness for implementing routine immunization among PPMVs. Given the high level of readiness, policy makers should consider the possibility of expanding access to immunization through PPMVs.
Item Type: | Journal Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Subjects: | K Law [Moys] > KR Africa R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology |
||||||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Population, Evidence & Technologies (PET) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||||
Library of Congress Subject Headings (LCSH): | Patent assertion entities, Patent assertion entities -- Nigeria -- Kano, Patent medicines , Patent medicines -- Nigeria -- Kano, Immunization, Immunization -- Nigeria -- Kano | ||||||||
Journal or Publication Title: | Expert Review of Vaccines | ||||||||
Publisher: | Taylor & Francis | ||||||||
ISSN: | 1476-0584 | ||||||||
Official Date: | 2020 | ||||||||
Dates: |
|
||||||||
Volume: | 19 | ||||||||
Number: | 4 | ||||||||
Page Range: | pp. 395-405 | ||||||||
DOI: | 10.1080/14760584.2020.1750379 | ||||||||
Status: | Peer Reviewed | ||||||||
Publication Status: | Published | ||||||||
Reuse Statement (publisher, data, author rights): | This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Vaccines on 10 Apr 2020, available online: http://www.tandfonline.com/10.1080/14760584.2020.1750379 | ||||||||
Access rights to Published version: | Open Access (Creative Commons) | ||||||||
Date of first compliant deposit: | 12 June 2020 | ||||||||
Date of first compliant Open Access: | 10 April 2021 |
Request changes or add full text files to a record
Repository staff actions (login required)
![]() |
View Item |
Downloads
Downloads per month over past year